NO20023298L - Nye imidazolderivater - Google Patents

Nye imidazolderivater

Info

Publication number
NO20023298L
NO20023298L NO20023298A NO20023298A NO20023298L NO 20023298 L NO20023298 L NO 20023298L NO 20023298 A NO20023298 A NO 20023298A NO 20023298 A NO20023298 A NO 20023298A NO 20023298 L NO20023298 L NO 20023298L
Authority
NO
Norway
Prior art keywords
imidazole derivatives
new imidazole
new
derivatives
imidazole
Prior art date
Application number
NO20023298A
Other languages
English (en)
Other versions
NO323117B1 (no
NO20023298D0 (no
Inventor
Paavo Huhtala
Arto Karjalainen
Antti Haapalinna
Jyrki Lehtimaeki
Arja Karjalainen
Raimo Virtanen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20023298D0 publication Critical patent/NO20023298D0/no
Publication of NO20023298L publication Critical patent/NO20023298L/no
Publication of NO323117B1 publication Critical patent/NO323117B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20023298A 2000-01-14 2002-07-08 Nye imidazolderivater NO323117B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000073A FI20000073A0 (fi) 2000-01-14 2000-01-14 Uusia imidatsolijohdannaisia
PCT/FI2001/000030 WO2001051472A1 (en) 2000-01-14 2001-01-12 New imidazole derivatives

Publications (3)

Publication Number Publication Date
NO20023298D0 NO20023298D0 (no) 2002-07-08
NO20023298L true NO20023298L (no) 2002-09-06
NO323117B1 NO323117B1 (no) 2007-01-08

Family

ID=8557065

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023298A NO323117B1 (no) 2000-01-14 2002-07-08 Nye imidazolderivater

Country Status (30)

Country Link
EP (1) EP1261588B1 (no)
JP (1) JP2003519688A (no)
KR (1) KR20020084091A (no)
CN (1) CN1187336C (no)
AR (1) AR029432A1 (no)
AT (1) ATE280161T1 (no)
AU (1) AU769896B2 (no)
BR (1) BR0107644A (no)
CA (1) CA2397283A1 (no)
CZ (1) CZ20022358A3 (no)
DE (1) DE60106572T2 (no)
DK (1) DK1261588T3 (no)
EE (1) EE200200389A (no)
ES (1) ES2228884T3 (no)
FI (1) FI20000073A0 (no)
GC (1) GC0000218A (no)
HK (1) HK1049999B (no)
HU (1) HUP0301008A3 (no)
IL (1) IL150506A0 (no)
MX (1) MXPA02006872A (no)
NO (1) NO323117B1 (no)
NZ (1) NZ519919A (no)
PE (1) PE20011230A1 (no)
PL (1) PL207281B1 (no)
PT (1) PT1261588E (no)
RU (1) RU2265598C2 (no)
SI (1) SI1261588T1 (no)
SK (1) SK286320B6 (no)
WO (1) WO2001051472A1 (no)
ZA (1) ZA200205301B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002756A0 (fi) * 2000-12-15 2000-12-15 Orion Yhtymae Oyj Uusi hoitomenetelmä
TW200930291A (en) * 2002-04-29 2009-07-16 Bayer Cropscience Ag Pesticidal heterocycles
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
DE102004035322A1 (de) * 2004-07-21 2006-02-16 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen
ATE546437T1 (de) 2006-10-19 2012-03-15 Hoffmann La Roche Aminomethyl-4-imidazole
JP2010510184A (ja) * 2006-11-16 2010-04-02 エフ．ホフマン−ラ ロシュ アーゲー 置換４−イミダゾール類
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
AR090557A1 (es) * 2012-04-02 2014-11-19 Orion Corp DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
US5541211A (en) * 1991-06-18 1996-07-30 Orion-Yhtyma Oy Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
RU2235092C2 (ru) * 1997-12-04 2004-08-27 Оллерган Инк. Замещенные производные имидазола, способ введения активного соединения и способ лечения на основе этих соединений
US6503935B1 (en) * 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors

Also Published As

Publication number Publication date
CA2397283A1 (en) 2001-07-19
KR20020084091A (ko) 2002-11-04
NZ519919A (en) 2003-10-31
CN1187336C (zh) 2005-02-02
AR029432A1 (es) 2003-06-25
ES2228884T3 (es) 2005-04-16
EP1261588B1 (en) 2004-10-20
EP1261588A1 (en) 2002-12-04
IL150506A0 (en) 2003-02-12
EE200200389A (et) 2003-10-15
WO2001051472A1 (en) 2001-07-19
HUP0301008A3 (en) 2004-01-28
FI20000073A0 (fi) 2000-01-14
NO323117B1 (no) 2007-01-08
WO2001051472A9 (en) 2003-01-23
NO20023298D0 (no) 2002-07-08
RU2002121777A (ru) 2004-01-10
CN1395567A (zh) 2003-02-05
SK9982002A3 (en) 2003-03-04
BR0107644A (pt) 2002-10-08
DK1261588T3 (da) 2005-02-14
SK286320B6 (en) 2008-07-07
RU2265598C2 (ru) 2005-12-10
SI1261588T1 (en) 2005-02-28
AU2853201A (en) 2001-07-24
MXPA02006872A (es) 2003-01-28
GC0000218A (en) 2006-03-29
AU769896B2 (en) 2004-02-05
PE20011230A1 (es) 2001-12-08
HK1049999A1 (en) 2003-06-06
ZA200205301B (en) 2003-10-02
ATE280161T1 (de) 2004-11-15
DE60106572T2 (de) 2006-02-09
HK1049999B (zh) 2005-05-13
CZ20022358A3 (cs) 2007-12-19
JP2003519688A (ja) 2003-06-24
PL207281B1 (pl) 2010-11-30
HUP0301008A2 (hu) 2003-10-28
PL356884A1 (en) 2004-07-12
PT1261588E (pt) 2005-02-28
DE60106572D1 (de) 2004-11-25

Similar Documents

Publication Publication Date Title
EE200300049A (et) Imidasooli derivaadid
ATE360620T1 (de) Imidazolderivate
DK1224180T3 (da) Substituerede azoler
NO20026064L (no) Nye forbindelser
NO20014518D0 (no) Nye forbindelser
DK1202994T3 (da) Nye forbindelser
NO20023934L (no) Nye forbindelser
ATE425147T1 (de) Imidazolderivate
NO20034970D0 (no) Nye arylheteroalkylaminderivater
NO20020810D0 (no) Nye fenylpiperaziner
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
NO20025151D0 (no) Nye forbindelser
NO20031141D0 (no) Nye forbindelser
DE50114491D1 (de) Substituierte C-Cyclohexylmethylamin-Derivative
NO20026162D0 (no) Nye forbindelser
DE50103035D1 (de) Substituierte 1-aminobutan-3-ol-derivate
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
NO20026081D0 (no) Nye forbindelser
NO20030274L (no) Nye aryleten-sulfonamider
NO20023298L (no) Nye imidazolderivater
NO20035248D0 (no) Nye fenylalkyloksy-fenyl derivater
ATE361274T1 (de) Substituierte 5-amino-1-penten-3-ol-derivate
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees